Apical thrombus in a patient with takotsubo cardiomyopathy.
We report a case of apical thrombus formation among a group of 15 patients with takotsubo cardiomyopathy who were referred for a suspected acute coronary syndrome over a 2.5-year period. To the best of our knowledge, no data are available regarding the treatment of this syndrome. According to current literature and our reported experience, the use of anticoagulant therapy administered until complete resolution of wall motion abnormalities appears to be appropriate to treat apical thrombus formation and any possible subsequent embolism.
Azzarelli
Salvatore
S
Division of Cardiology, 'Cannizzaro' Hospital, Catania, Italy. azzarelli.s@tiscali.it
Galassi
Alfredo R
AR
Amico
Francesco
F
Giacoppo
Michele
M
Argentino
Vincenzo
V
Giordano
Guido
G
Fiscella
Antonio
A
D000284:Administration, Oral; D001241:Aspirin / Q000008:administration & dosage*; D017023:Coronary Angiography; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004452:Echocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006331:Heart Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D009200:Myocardial Contraction; D054549:Takotsubo Cardiomyopathy / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D013927:Thrombosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
D005343:Fibrinolytic Agents; D006493:Heparin; D001241:Aspirin